Next generation sequencing (NGS)-based approach to diagnosing Algerian patients with suspected inborn errors of immunity (IEIs)

Tangye, 2022, Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee, J. Clin. Immunol., 42, 1473, 10.1007/s10875-022-01289-3 Casanova, 2022, From rare disorders of immunity to common determinants of infection: following the mechanistic thread, Cell., 185, 3086, 10.1016/j.cell.2022.07.004 Lee, 2021, Next-generation sequencing for inborn errors of immunity, Hum. Immunol., 82, 871, 10.1016/j.humimm.2021.02.011 Platt, 2021, Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency, J. Allergy Clin. Immunol., 147, 723, 10.1016/j.jaci.2020.08.022 Yska, 2019, Diagnostic yield of next generation sequencing in genetically undiagnosed patients with primary Immunodeficiencies: a systematic review, J. Clin. Immunol., 39, 577, 10.1007/s10875-019-00656-x Ripen, 2021, A single-center pilot study in Malaysia on the clinical utility of whole-exome sequencing for inborn errors of immunity, Clin. Exp. Immunol., 206, 119, 10.1111/cei.13626 Vorsteveld, 2021, Next-generation sequencing in the field of primary Immunodeficiencies: current yield, challenges, and future perspectives, Clin. Rev. Allergy Immunol., 61, 212, 10.1007/s12016-021-08838-5 Tengsujaritkul, 2022, Phenotypic heterogeneity and genotypic spectrum of inborn errors of immunity identified through whole exome sequencing in a Thai patient cohort, Pediatr. Allergy Immunol., 33, 10.1111/pai.13701 Lionel, 2018, Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test, Genet. Med., 20, 435, 10.1038/gim.2017.119 Meyts, 2016, Exome and genome sequencing for inborn errors of immunity, J. Allergy Clin. Immunol., 138, 957, 10.1016/j.jaci.2016.08.003 Elsink, 2021, Implementation of early next-generation sequencing for inborn errors of immunity: a prospective observational cohort study of diagnostic yield and clinical implications in Dutch genome diagnostic centers, Front. Immunol., 12, 10.3389/fimmu.2021.780134 Grossi, 2021, Targeted NGS yields plentiful ultra-rare variants in inborn errors of immunity patients, Genes, 12 Rawat, 2022, Utility of targeted next generation sequencing for inborn errors of immunity at a tertiary care Centre in North India, Sci. Rep., 12, 10416, 10.1038/s41598-022-14522-1 Bekada, 2015, Genetic heterogeneity in Algerian human populations, PLoS One, 10, 10.1371/journal.pone.0138453 Stoltenberg, 2009, Commentary: of the same blood, Int. J. Epidemiol., 1442, 10.1093/ije/dyp312 Anwar, 2014, Consanguinity and genetic diseases in North Africa and immigrants to Europe, Eur. J. Pub. Health, 24, 57, 10.1093/eurpub/cku104 Peng, 2023, Common variable immunodeficiency: more pathways than roads to Rome, Annu. Rev. Pathol., 18, 283, 10.1146/annurev-pathmechdis-031521-024229 Nambu, 2022, A systematic review of monogenic inflammatory bowel disease, Clin. Gastroenterol. Hepatol., 20, e653, 10.1016/j.cgh.2021.03.021 Economou, 2004, Differential effects of NOD2 variants on Crohn’s disease risk and phenotype in diverse populations: a metaanalysis, Am. J. Gastroenterol., 99, 2393, 10.1111/j.1572-0241.2004.40304.x Tsilifis, 2021, STAT3 hyper-IgE syndrome-an update and unanswered questions, J. Clin. Immunol., 41, 864, 10.1007/s10875-021-01051-1 Zhang, 2018, Human hyper-IgE syndrome: singular or plural?, Mamm. Genome, 29, 603, 10.1007/s00335-018-9767-2 Stray-Pedersen, 2014, PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia, Am. J. Hum. Genet., 95, 96, 10.1016/j.ajhg.2014.05.007 Kreins, 2015, Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome, J. Exp. Med., 212, 1641, 10.1084/jem.20140280 Puel, 2020, Human inborn errors of immunity underlying superficial or invasive candidiasis, Hum. Genet., 139, 1011, 10.1007/s00439-020-02141-7 Okada, 2020, Human STAT1 gain-of-function heterozygous mutations: chronic Mucocutaneous candidiasis and type I Interferonopathy, J. Clin. Immunol., 40, 1065, 10.1007/s10875-020-00847-x Rojas-Restrepo, 2021, Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: experience from a monocentric study, Front. Immunol., 12, 10.3389/fimmu.2021.786516 Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet. Med., 17, 405, 10.1038/gim.2015.30 Janzi, 2012, Rare mutations in TNFRSF13B increase the risk of asthma symptoms in Swedish children, Genes Immun., 13, 59, 10.1038/gene.2011.55 Freiberger, 2012, Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations, Hum. Immunol., 73, 1147, 10.1016/j.humimm.2012.07.342 Chase, 2013, Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID), J. Clin. Immunol., 33, 30, 10.1007/s10875-012-9755-3 Pulvirenti, 2016, Clinical associations of Biallelic and Monoallelic TNFRSF13B variants in Italian primary antibody deficiency syndromes, J Immunol Res, 2016, 8390356, 10.1155/2016/8390356 Lougaris, 2014, BAFF-R mutations in Good’s syndrome, Clin. Immunol., 153, 91, 10.1016/j.clim.2014.04.002 Rudilla, 2019, Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings, Front. Immunol., 10, 2325, 10.3389/fimmu.2019.02325 Salzer, 2009, Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes, Blood., 113, 1967, 10.1182/blood-2008-02-141937 Fried, 2011, Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency, J. Allergy Clin. Immunol., 128, 226, 10.1016/j.jaci.2011.01.048 Nekrep, 2003, When the lymphocyte loses its clothes, Immunity., 18, 453, 10.1016/S1074-7613(03)00086-4 Hanna, 2014, MHC class I and II deficiencies, J. Allergy Clin. Immunol., 134, 269, 10.1016/j.jaci.2014.06.001 Wiszniewski, 2000, Founder effect for a 26-bp deletion in the RFXANK gene in north African major histocompatibility complex class II-deficient patients belonging to complementation group B, Immunogenetics., 51, 261, 10.1007/s002510050619 Naamane, 2010, The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population, Eur. J. Pediatr., 169, 1069, 10.1007/s00431-010-1179-6 Ouederni, 2011, Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients, Blood., 118, 5108, 10.1182/blood-2011-05-352716 Guirat-Dhouib, 2012, Oral HPV infection and MHC class II deficiency (a study of two cases with atypical outcome), Clin. Mol. Allerg., 10, 6, 10.1186/1476-7961-10-6 Djidjik, 2012, Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency, Allergy, Asthma Clin. Immunol., 8, 14, 10.1186/1710-1492-8-14 Ben Halim, 2013, Consanguinity, endogamy, and genetic disorders in Tunisia, J. Communit. Genet., 4, 273, 10.1007/s12687-012-0128-7 Ben-Mustapha, 2013, Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients, J. Clin. Immunol., 33, 865, 10.1007/s10875-013-9863-8 Barbouche, 2017, Lessons from genetic studies of primary Immunodeficiencies in a highly consanguineous population, Front. Immunol., 8, 737, 10.3389/fimmu.2017.00737 Al-Mousa, 2023, Genetics of inborn errors of immunity in highly consanguineous middle eastern and north African populations, Semin. Immunol., 67, 10.1016/j.smim.2023.101763 Al-Herz, 2013, Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile, J. Clin. Immunol., 33, 513, 10.1007/s10875-012-9831-8 Reith, 2001, The bare lymphocyte syndrome and the regulation of MHC expression, Annu. Rev. Immunol., 19, 331, 10.1146/annurev.immunol.19.1.331 Elhasid, 1996, Major histocompatibility complex class II deficiency: a clinical review, Blood Rev., 10, 242, 10.1016/S0268-960X(96)90008-9 Janssen, 2022, Immune dysregulation caused by homozygous mutations in CBLB, J. Clin. Invest., 132 Notarangelo, 2003, Wiskott-Aldrich syndrome: a model for defective actin reorganization, cell trafficking and synapse formation, Curr. Opin. Immunol., 15, 585, 10.1016/S0952-7915(03)00112-2 Snapper, 2005, WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo, J. Leukoc. Biol., 77, 993, 10.1189/jlb.0804444 Orange, 2002, Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses, Proc. Natl. Acad. Sci. U. S. A., 99, 11351, 10.1073/pnas.162376099 Strom, 2009, The thrombocytopenia of WAS: a familial form of ITP?, Immunol. Res., 44, 42, 10.1007/s12026-008-8069-2 Schindelhauer, 1996, Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product, Hum. Genet., 98, 68, 10.1007/s004390050162 Wang, 2020, Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China, Hum. Genet., 139, 473, 10.1007/s00439-019-02103-8 Arunachalam, 2021, Primary Immunodeficiencies in India: molecular diagnosis and the role of next-generation sequencing, J. Clin. Immunol., 41, 393, 10.1007/s10875-020-00923-2 Cavannaugh, 2022, Diagnosis and clinical management of Wiskott-Aldrich syndrome: current and emerging techniques, Expert. Rev. Clin. Immunol., 18, 609, 10.1080/1744666X.2022.2074400 Chen, 2017, Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity, Cell., 170, 492, 10.1016/j.cell.2017.06.042 Zhang, 2015, PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection, Nat. Immunol., 16, 1215, 10.1038/ni.3279 Toubiana, 2016, Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype, Blood., 127, 3154, 10.1182/blood-2015-11-679902 Takezaki, 2012, Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain, J. Immunol., 189, 1521, 10.4049/jimmunol.1200926 Sampaio, 2013, Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis, J. Allergy Clin. Immunol., 131, 1624, 10.1016/j.jaci.2013.01.052 Soltész, 2013, New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from eastern and Central Europe, J. Med. Genet., 50, 567, 10.1136/jmedgenet-2013-101570 Uzel, 2013, Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome, J. Allergy Clin. Immunol., 131, 1611, 10.1016/j.jaci.2012.11.054 Sharfe, 2014, Fatal combined immunodeficiency associated with heterozygous mutation in STAT1, J. Allergy Clin. Immunol., 133, 807, 10.1016/j.jaci.2013.09.032 Frans, 2014, Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding, J. Allergy Clin. Immunol., 134, 1209, 10.1016/j.jaci.2014.05.044 Depner, 2016, The extended clinical phenotype of 26 patients with chronic Mucocutaneous candidiasis due to gain-of-function mutations in STAT1, J. Clin. Immunol., 36, 73, 10.1007/s10875-015-0214-9 Zerbe, 2016, Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature, Clin. Infect. Dis., 62, 986, 10.1093/cid/civ1220 Baris, 2016, Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1, J. Clin. Immunol., 36, 641, 10.1007/s10875-016-0312-3 Stray-Pedersen, 2017, Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders, J. Allergy Clin. Immunol., 139, 232, 10.1016/j.jaci.2016.05.042 Eslami, 2017, A gain-of-function mutation of STAT1: a novel genetic factor contributing to chronic mucocutaneous candidiasis, Acta Microbiol. Immunol. Hung., 64, 191, 10.1556/030.64.2017.014 Eren Akarcan, 2017, Gain-of-function mutations in STAT1: a recently defined cause for chronic Mucocutaneous candidiasis disease mimicking combined Immunodeficiencies, Case Report. Immunol., 2017, 2846928 Russell, 1995, Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development, Science., 270, 797, 10.1126/science.270.5237.797 Mella, 2001, Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain, Hum. Mutat., 18, 355, 10.1002/humu.1199 Frucht, 2001, Unexpected and variable phenotypes in a family with JAK3 deficiency, Genes Immun., 2, 422, 10.1038/sj.gene.6363802 Casanova, 2012, Inborn errors of human JAKs and STATs, Immunity., 36, 515, 10.1016/j.immuni.2012.03.016 Asgardoon, 2020, Monogenic primary immunodeficiency disorder associated with common variable immunodeficiency and autoimmunity, Int. Arch. Allergy Immunol., 181, 706, 10.1159/000508817 Abolhassani, 2015, Common variable immunodeficiency or late-onset combined immunodeficiency: a new Hypomorphic JAK3 patient and review of the literature, J Investig Allergol Clin Immunol, 25, 218 Scarselli, 2016, Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma, J. Allergy Clin. Immunol., 137, 948, 10.1016/j.jaci.2015.09.017 Abolhassani, 2020, Current genetic landscape in common variable immune deficiency, Blood., 135, 656, 10.1182/blood.2019000929 Cai, 2022, Common variable immunodeficiency with JAK3 mutation: a case report, Zhonghua Xue Ye Xue Za Zhi, 43, 79 Keller, 2018, Germline deletion of CIN85 in humans with X chromosome-linked antibody deficiency, J. Exp. Med., 215, 1327, 10.1084/jem.20170534 Ben-Chetrit, 2009, Familial mediterranean fever in the world, Arthritis Rheum., 61, 1447, 10.1002/art.24458 Sarı, 2014, Familial Mediterranean fever: an updated review, Eur. J. Rheumatol. Inflamm., 1, 21, 10.5152/eurjrheum.2014.006 Alghamdi, 2017, Familial Mediterranean fever, review of the literature, Clin. Rheumatol., 36, 1707, 10.1007/s10067-017-3715-5 Fidder, 2002, Crohn disease in patients with familial Mediterranean fever, Medicine, 81, 411, 10.1097/00005792-200211000-00001 Sari, 2008, The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy, Eur. J. Pediatr., 167, 391, 10.1007/s00431-007-0508-x Uslu, 2010, The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children, Dig. Dis. Sci., 55, 3488, 10.1007/s10620-010-1178-5 Akyuz, 2013, Association of the MEFV gene variations with inflammatory bowel disease in Turkey, J. Clin. Gastroenterol., 47, e23, 10.1097/MCG.0b013e3182597992 Beşer OF, 2013, Association of inflammatory bowel disease with familial Mediterranean fever in Turkish children, J. Pediatr. Gastroenterol. Nutr., 56, 498, 10.1097/MPG.0b013e31827dd763 Beşer, 2014, Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease, Turk. Pediatri. Ars., 49, 198, 10.5152/tpa.2014.1998 Özçakar, 2017, Familial Mediterranean fever-associated diseases in children, QJM., 110, 287 Atas, 2020, Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study, Rheumatol. Int., 40, 41, 10.1007/s00296-019-04412-7 Mor, 2003, Abdominal and digestive system associations of familial Mediterranean fever, Am. J. Gastroenterol., 98, 2594, 10.1111/j.1572-0241.2003.08784.x Arasawa, 2012, Mediterranean mimicker, Lancet., 380, 2052, 10.1016/S0140-6736(12)61377-4 Kuloğlu, 2012, An infant with severe refractory Crohn’s disease and homozygous MEFV mutation who dramatically responded to colchicine, Rheumatol. Int., 32, 783, 10.1007/s00296-009-1326-4 Asakura, 2018, Familial Mediterranean fever mimicking Crohn disease: a case report, Medicine, 97, 10.1097/MD.0000000000009547 Saito, 2020, MEFV gene-related enterocolitis account for some cases diagnosed as inflammatory bowel disease unclassified, Digestion., 101, 785, 10.1159/000502640 Yokoyama, 2021, Gastrointestinal involvement in a patient with familial Mediterranean fever mimicking Crohn’s disease: a case report, Clin. J. Gastroenterol., 14, 1103, 10.1007/s12328-021-01426-2 Fidder, 2005, The familial Mediterranean fever (MEVF) gene as a modifier of Crohn’s disease, Am. J. Gastroenterol., 100, 338, 10.1111/j.1572-0241.2005.40810.x Karban, 2005, Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn’s disease, Genes Immun., 6, 134, 10.1038/sj.gene.6364156 Renda, 2008, Familial Mediterranean fever gene (MEVF) mutations in Crohn’s disease in a Mediterranean area, Inflamm. Bowel Dis., 14, 1313, 10.1002/ibd.20424 Sahin, 2021, Evaluation of the clinical effects and frequency of MEFV gene mutation in patients with inflammatory bowel disease, Gastroenterol. Res. Pract., 2021, 5538150, 10.1155/2021/5538150 Urgancı, 2021, Familial Mediterranean fever mutation analysis in pediatric patients with İnflammatory bowel disease: a multicenter study, Turk J Gastroenterol, 32, 248, 10.5152/tjg.2021.20057 Papadopoulos, 2022, MEFV mutations in IBD patients: a systematic review and Meta- analysis, J. Gastrointestin. Liver Dis., 31, 85, 10.15403/jgld-4070 Bernot, 1998, Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF), Hum. Mol. Genet., 7, 1317, 10.1093/hmg/7.8.1317 Sedivá, 2014, Cluster of patients with familial Mediterranean fever and heterozygous carriers of mutations in MEFV gene in the Czech Republic, Clin. Genet., 86, 564, 10.1111/cge.12323 Milenković, 2016, Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation, Pediatr. Rheumatol. Online J., 14, 39, 10.1186/s12969-016-0097-1 Berdeli, 2011, Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a “heterozygote advantage” in Turkey?, Genet. Test. Mol. Biomarkers, 15, 475, 10.1089/gtmb.2010.0146 Ozturk, 2012, Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey, Clin Rheumatol., 31, 493, 10.1007/s10067-011-1876-1 Fujikura, 2015, Global epidemiology of familial Mediterranean fever mutations using population exome sequences, Mol. Genet. Genom. Med., 3, 272, 10.1002/mgg3.140 Salehzadeh, 2014, PFAPA and 12 common MEFV gene mutations our clinical experience, Iran. J. Pediatr., 24, 64 Van Gorp, 2020, Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever, Ann. Rheum. Dis., 79, 960, 10.1136/annrheumdis-2019-216701 Honda, 2021, Rapid flow cytometry-based assay for the functional classification of MEFV variants, J. Clin. Immunol., 41, 1187, 10.1007/s10875-021-01021-7 Papa, 2017, A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry, Orphanet J. Rare Dis., 12, 167, 10.1186/s13023-017-0720-3 Aksentijevich, 1999, Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population, Am. J. Hum. Genet., 64, 949, 10.1086/302327 Gershoni-Baruch, 2002, Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability, Am. J. Med. Genet., 109, 198, 10.1002/ajmg.10352 Van Gijn, 2018, New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the international study Group for Systemic Autoinflammatory Diseases (INSAID), J. Med. Genet., 55, 530, 10.1136/jmedgenet-2017-105216 Dittmar, 2009, A novel mutation in the DNASE1 gene is related with protein instability and decreased enzyme activity in thyroid autoimmunity, J. Autoimmun., 32, 7, 10.1016/j.jaut.2008.09.005 Ueki, 2019, Evaluation of the functional effects of genetic variants–missense and nonsense SNPs, indels and copy number variations–in the gene encoding human deoxyribonuclease I potentially implicated in autoimmunity, Sci. Rep., 9, 13660, 10.1038/s41598-019-49935-y Shak, 1990, Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum, Proc. Natl. Acad. Sci. U. S. A., 87, 9188, 10.1073/pnas.87.23.9188 Oliveri, 2001, DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis, Eur. J. Immunol., 31, 743, 10.1002/1521-4141(200103)31:3<743::AID-IMMU743>3.0.CO;2-9 Yasuda, 1990, Human genetically polymorphic deoxyribonuclease: purification, characterization, and multiplicity of urine deoxyribonuclease I, J. Biochem., 108, 393, 10.1093/oxfordjournals.jbchem.a123212 Yasutomo, 2001, Mutation of DNASE1 in people with systemic lupus erythematosus, Nat. Genet., 28, 313, 10.1038/91070 Belguith-Maalej, 2009, DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren syndrome and healthy subjects, Rheumatol. Int., 30, 69, 10.1007/s00296-009-0917-4 San, 2006, Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review, Cutis., 78, 57 de Moraes-Vasconcelos, 2012, Chronic mucocutaneous candidiasis and systemic lupus erythematosus: a new variant of chronic mucocutaneous candidiasis?, Med. Mycol., 50, 399, 10.3109/13693786.2011.622305 Fangtham, 2014, Oral candidiasis in systemic lupus erythematosus, Lupus., 23, 684, 10.1177/0961203314525247 Su, 2021, Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study, Ther. Adv. Musculoskelet. Dis., 13, 10.1177/1759720X211058502 Maddur, 2010, Autoimmunity as a predisposition for infectious diseases, PLoS Pathog., 6, 10.1371/journal.ppat.1001077 Ammar, 2016, CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts, Br. J. Dermatol., 174, 330, 10.1111/bjd.14158 Waldman, 2001, Incidence of Candida in psoriasis--a study on the fungal flora of psoriatic patients, Mycoses., 44, 77, 10.1046/j.1439-0507.2001.00608.x Taheri Sarvtin, 2014, Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis, Int. J. Dermatol., 53, e555, 10.1111/ijd.12562 Pietrzak, 2018, Prevalence and possible role of Candida species in patients with psoriasis: a systematic review and Meta-analysis, Mediat. Inflamm., 2018, 9602362, 10.1155/2018/9602362 Chadeganipour, 2021, Fungal infections among psoriatic patients: etiologic agents, comorbidities, and vulnerable population, Autoimmune Dis., 2021, 1174748 Elsner, 2022, Prevalence of Candida species in psoriasis, Mycoses., 65, 247, 10.1111/myc.13399 Puel, 2011, Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity, Science., 332, 65, 10.1126/science.1200439 Christiansen, 2019, Identification of novel genetic variants in CVID patients with autoimmunity, autoinflammation, or malignancy, Front. Immunol., 10, 3022, 10.3389/fimmu.2019.03022 Goepfert, 2017, The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties, Sci. Rep., 7, 8906, 10.1038/s41598-017-08360-9 Soderstrom, 2017, Ultra-sensitive measurement of IL-17A and IL-17F in psoriasis patient serum and skin, AAPS J., 19, 1218, 10.1208/s12248-017-0094-4 Draberova, 2020, Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop, EMBO J., 39, 10.15252/embj.2019104202 Sherman, 2019, Assembly of a pan-genome from deep sequencing of 910 humans of African descent, Nat. Genet., 51, 30, 10.1038/s41588-018-0273-y Ebert, 2021, Haplotype-resolved diverse human genomes and integrated analysis of structural variation, Science., 372 Thaxton, 2022, Utilizing ClinGen gene-disease validity and dosage sensitivity curations to inform variant classification, Hum. Mutat., 43, 1031, 10.1002/humu.24291 Smith, 2022, Inborn errors of immunity associated with type 2 inflammation in the USIDNET registry, Front. Immunol., 13, 10.3389/fimmu.2022.831279 Aghamohammadi, 2021, Consensus Middle East and North Africa registry on inborn errors of immunity, J. Clin. Immunol., 41, 1339, 10.1007/s10875-021-01053-z Jamee, 2022, Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry, Clin. Immunol., 244, 10.1016/j.clim.2022.109131 Abolhassani, 2018, Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency, J. Allergy Clin. Immunol., 141, 1450, 10.1016/j.jaci.2017.06.049 Abolhassani, 2020, Global systematic review of primary immunodeficiency registries, Expert. Rev. Clin. Immunol., 16, 717, 10.1080/1744666X.2020.1801422 Engelbrecht, 2021, Clinical utility of whole exome sequencing and targeted panels for the identification of inborn errors of immunity in a resource-constrained setting, Front. Immunol., 12, 10.3389/fimmu.2021.665621 El Hawary, 2022, Genetic testing in Egyptian patients with inborn errors of immunity: a single-center experience, J. Clin. Immunol., 42, 1051, 10.1007/s10875-022-01272-y Moens, 2014, Diagnostics of primary immunodeficiency diseases: a sequencing capture approach, PLoS One, 9, 10.1371/journal.pone.0114901 Wortmann, 2022, How to proceed after “negative” exome: a review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques, J. Inherit. Metab. Dis., 45, 663, 10.1002/jimd.12507 Sahajpal, 2022, Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19, iScience., 25, 10.1016/j.isci.2022.103760 Noyes, 2022, Familial long-read sequencing increases yield of de novo mutations, Am. J. Hum. Genet., 109, 631, 10.1016/j.ajhg.2022.02.014 Baris, 2023, The Middle East and North Africa diagnosis and management guidelines for inborn errors of immunity, J Allergy Clin Immunol Pract, 11, 158, 10.1016/j.jaip.2022.10.003